Gregorio Laguna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gregorio Laguna has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Miriam Blanco
Cardiac Surgery Department, Clinic University Hospital of Valladolid, Valladolid, Spain
8 shared publications- Yolanda Carrascal
Servicio de Cirugía Cardiaca, Hospital Clínico Universitario de Valladolid, Valladolid, Spain; Departamento de Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia, Universidad de Valladolid, Valladolid, Spain
5 shared publications Nuria Arce
Department of Cardiac Surgery, Hospital Clínico Universitario, Valladolid, Spain
4 shared publicationsSalvatore Di Stefano
Department of Cardiac Surgery, Hospital Clínico Universitario, Valladolid, Spain
3 shared publicationsYolanda Carrascal
Cardiac Surgery Department, Clinic University Hospital of Valladolid, Valladolid, Spain
3 shared publicationsGerardo Martínez
Anatomical Pathology Department, Clinic University Hospital of Valladolid, Valladolid, Spain
2 shared publications
Latest Publications
- Open Access
- 13 June 2019
- Published by Universidad de Valladolid
Efecto del trasplante de células madre mononucleadas autólogas derivadas de la médula ósea mediante inyección intramiocárdica directa asociado a revascularización coronaria quirúrgica sobre la función miocárdica y el remodelado ventricular postinfarto de miocardio transmural en fase subaguda
- 13 June 2019
- Published by Universidad de Valladolid
Open AccessEfecto del trasplante de células madre mononucleadas autólogas derivadas de la médula ósea mediante inyección intramiocárdica directa asociado a revascularización coronaria quirúrgica sobre la función miocárdica y el remodelado ventricular postinfarto de miocardio transmural en fase subaguda
- 1 December 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 106 (6) , E321-E322
Pericardial Pleomorphic Mesothelioma and Heart Failure: A Unique Case
- 1 December 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 106 (6) , E321-E322
Pericardial Pleomorphic Mesothelioma and Heart Failure: A Unique Case
- Open Access
- 30 October 2018
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 25 (5) , 652-654
Giant left atrial myxoma hiding severe preoperative mitral regurgitation
- 30 October 2018
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 25 (5) , 652-654
Open AccessGiant left atrial myxoma hiding severe preoperative mitral regurgitation
- 1 August 2018
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 156 (2) , 777-779
Subaortic stenosis by accessory mitral tissue: Failure of embryonic positioning?
- 1 August 2018
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 156 (2) , 777-779
Subaortic stenosis by accessory mitral tissue: Failure of embryonic positioning?
- 1 March 2018
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 59 (2) , 259-267
Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction
Article: Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction - The Journal of Cardiovascular Surgery 2018 April;59(2):259-67 - Minerva Medica - Journals
- 1 March 2018
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 59 (2) , 259-267
Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction
Article: Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction - The Journal of Cardiovascular Surgery 2018 April;59(2):259-67 - Minerva Medica - Journals
- Open Access
- 1 January 2018
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 111 (3) , 434-435
Right Ventricular Wound And Complete Mammary Artery Transection
- 1 January 2018
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 111 (3) , 434-435
Open AccessRight Ventricular Wound And Complete Mammary Artery Transection
- 1 September 2017
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 104 (3) , e285
Isolated Infective Endocarditis of the Left Ventricular Outflow Tract and Multiple Septic Embolisms
- 1 September 2017
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 104 (3) , e285
Isolated Infective Endocarditis of the Left Ventricular Outflow Tract and Multiple Septic Embolisms
- Open Access
- 28 March 2016
- Published by Wiley in Journal of Arrhythmia
- Vol. 32 (3) , 191-197
Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry)
Background: To evaluate the efficacy of perioperative atorvastatin administration for prophylaxis of postoperative atrial fibrillation (POAF) after heart valve surgery.Methods: Our study included 90 patients with heart valve disease who were scheduled to undergo elective cardiac surgery. Cases with previous AF or preoperative beta‐blocker therapy were excluded. Patients were randomized into the atorvastatin group, which included 47 patients who received 40 mg/day of atorvastatin 7 days before and after the surgery and the control group, which included 43 patients. Primary endpoint was the occurrence of POAF. Secondary endpoints included modifications in the preoperative and postoperative levels of the markers of inflammation (C‐reactive protein [CRP]), myocardial injury (ultrasensitive troponin T and creatinine phosphokinase MB [CPK‐MB]), and cardiac dysfunction (pro‐brain natriuretic peptide [proBNP]) related to POAF and changes in the echocardiographic parameters, such as atrial electromechanical interval, A wave, E/A ratio, and Doppler imaging systolic velocity wave amplitude, related to POAF.Results: No relationship between atorvastatin administration and reduction in the incidence of POAF was observed (42.6% in the atorvastatin vs. 30.2% in the control group) (p=0.226). No difference in the levels of CPK‐MB, ultrasensitive troponin T, CRP, or proBNP and in the analyzed echocardiographic parameter was detected between both groups.Conclusions: Atorvastatin in the described dose, was not adequate for the prophylaxis of POAF after heart valve surgery. It was ineffective in controlling the inflammatory phenomena, myocardial injury, and echocardiographic predictors of POAF.
- 28 March 2016
- Published by Wiley in Journal of Arrhythmia
- Vol. 32 (3) , 191-197
Open AccessEfficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry)
Background: To evaluate the efficacy of perioperative atorvastatin administration for prophylaxis of postoperative atrial fibrillation (POAF) after heart valve surgery.Methods: Our study included 90 patients with heart valve disease who were scheduled to undergo elective cardiac surgery. Cases with previous AF or preoperative beta‐blocker therapy were excluded. Patients were randomized into the atorvastatin group, which included 47 patients who received 40 mg/day of atorvastatin 7 days before and after the surgery and the control group, which included 43 patients. Primary endpoint was the occurrence of POAF. Secondary endpoints included modifications in the preoperative and postoperative levels of the markers of inflammation (C‐reactive protein [CRP]), myocardial injury (ultrasensitive troponin T and creatinine phosphokinase MB [CPK‐MB]), and cardiac dysfunction (pro‐brain natriuretic peptide [proBNP]) related to POAF and changes in the echocardiographic parameters, such as atrial electromechanical interval, A wave, E/A ratio, and Doppler imaging systolic velocity wave amplitude, related to POAF.Results: No relationship between atorvastatin administration and reduction in the incidence of POAF was observed (42.6% in the atorvastatin vs. 30.2% in the control group) (p=0.226). No difference in the levels of CPK‐MB, ultrasensitive troponin T, CRP, or proBNP and in the analyzed echocardiographic parameter was detected between both groups.Conclusions: Atorvastatin in the described dose, was not adequate for the prophylaxis of POAF after heart valve surgery. It was ineffective in controlling the inflammatory phenomena, myocardial injury, and echocardiographic predictors of POAF.
- 1 April 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (4) , 340
Left Ventricular Pseudoaneurysm Following Thoracic Aorta Replacement
- 1 April 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (4) , 340
Left Ventricular Pseudoaneurysm Following Thoracic Aorta Replacement
- 1 March 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (3) , 274
Chiari Network and Paradoxical Embolism. Response
- 1 March 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (3) , 274
Chiari Network and Paradoxical Embolism. Response